Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ACN vs GSK✓SelectedUSD · GSKACN vs GSK performance historyLatest closeAs of+1.18%11/20
Stock and ETF performance explorer

ACN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+118.3%
GSK return
+97.4%
Excess return
+20.8%
Maximum drawdown
-68.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.2%-0.1%+1.3%+1.2%
7D-11.7%-5.3%-6.4%-9.9%
30D-7.9%-3.7%-4.3%-6.7%
3M+22.9%-7.3%+30.2%+26.3%
6M+25.9%-4.2%+30.1%+27.9%
YTD-15.2%+0.9%-16.1%-16.4%
1Y-5.5%+7.3%-12.8%-9.1%
3Y-29.1%+52.7%-81.9%-42.8%
5Y-34.7%+40.1%-74.8%-46.2%
All+118.3%+97.4%+20.8%+54.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling